HCC, n = 73 | Cirrhotic, n = 85 | Test of significance | |
---|---|---|---|
Age/years, mean ± SD | 56.21 ± 4.62 | 54.27 ± 7.63 | t = 1.89 P = 0.06 |
Sex, N (%) | |||
Male | 43 (58.9%) | 39 (45.9%) | χ2 = 2.67 P = 0.102 |
Female | 30 (41.1%) | 46 (54.1%) | |
DM, N (%) | 31 (42.5%) | 27 (31.8%) | χ2 = 1.94 P = 0.164 |
Hypertension, N (%) | 19 (26.0%) | 23 (27.1%) | χ2 = 0.021 P = 0.884 |
Albumin (gm/dl), mean ± SD | 3.29 ± 0.59 | 3.56 ± 0.52 | t = 2.98 P = 0.003* |
Bilirubin (mg/dl), median (IQR) | 1.2 (0.85–1.7) | 1.2 (0.8–1.64) | z = 0.821 P = 0.412 |
WBCS, mean ± SD | 4.78 ± 1.88 | 4.69 ± 1.85 | t = 0.33 P = 0.739 |
HB (gm/dl), mean ± SD | 11.33 ± 1.66 | 11.42 ± 1.53 | t = 0.374 P = 0.709 |
Platelets ˣ 103, mean ± SD | 101.05 ± 44.17 | 123.92 ± 36.76 | t = 3.55 P = 0.001* |
ALT (U/l), median (IQR) | 35.0 (28.5–47.0) | 35.0 (29.0–45.0) | z = 0.452 P = 0.65 |
AFP (ng/dl), median (IQR) | 89.0 (33.0–230.5) | 5.2 (2.8–9.7) | z = 9.98 P < 0.001* |
AST(U/l), median (IQR) | 68.0 (54.5–89.0) | 40.0(36.0–47.0) | z = 7.67 P < 0.001* |
INR, mean ± SD | 1.36 ± 0.20 | 1.32 ± 0.19 | t = 1.09 P = 0.275 |